Table of Contents
The Colket Translational Research Building at Children’s Hospital of Philadelphia
The Colket Translational Research Building is home to a number of innovative research facilities. It has 1,000,000 square feet of biomedical space, LEED Gold certification, and a Center for Cellular and Molecular Therapeutics. The facility has been designed to foster close collaboration among scientists, resulting in innovative ideas and faster results. Each of the building’s six floors features state-of-the-art laboratories, and it is designed to accommodate an additional 12 floors.
1,000,000 SF of biomedical research
The Children’s Hospital of Philadelphia’s new state-of-the-art laboratory space is home to the Center for Childhood Cancer Research and the Center for Cellular and Molecular Therapeutics. This facility is dedicated to turning pediatric science into medical breakthroughs. The building is the first phase of CHoP’s south campus expansion. It includes four floors of biomedical research laboratories, a cafeteria, conference rooms, and administrative offices. Eventually, the building is expected to rise 27 stories, providing even more space for research and clinical care.
The new building’s first floor is dedicated to mitochondria research. Mitochondria are the tiny power plants of human cells, and diseases affecting mitochondria can result in a wide range of physical and mental health issues. For example, improperly functioning mitochondria can lead to epilepsy, Parkinson’s disease, and Alzheimer’s disease. Children’s Hospital is home to one of the world’s leading experts in mitochondrial genetics. He is working with CHOP to understand the evolution of mitochondria and their role in early human migrations.
LEED Gold certification
The Colket Translational Research Building at Children’s Hospital of Philadelphia is a four-story research facility that combines researchers from various fields into one collaborative environment. With a total budget of $496 million, the project is designed to be both energy efficient and environmentally responsible. Its green features include light harvesting, energy recovery systems, and low-flow plumbing.
The building will allow scientists to work side by side and foster close collaboration, leading to new ideas and faster results. It will also have state-of-the-art laboratory space, with the ability to expand the building by an additional twelve floors. The Colket Translational Research Building is LEED Gold-certified and will have multiple fire compartments.
The building also features a 14,000-square-foot rooftop garden and a landscaped plaza. The building was designed from the ground up to be energy efficient. Ultimately, the Colket Translational Research Building will house up to 50 principal investigators and their teams.
Center for Childhood Cancer Research
The new Center for Childhood Cancer Research translational research building is a state-of-the-art laboratory facility that houses the Center for Childhood Cancer Research and the Center for Cellular and Molecular Therapeutics. Both of these centers turn pediatric science into medical innovation. The building features four floors of laboratory space, a cafeteria, conference rooms, and administrative offices. When complete, the building will be 27 stories high.
The Center for Childhood Cancer Research is dedicated to ensuring that children who are diagnosed with cancer will receive the best treatment possible. It brings together the expertise of many investigators from across the Hospital’s multidisciplinary program to advance research in pediatric cancer. Its goal is to find new, more effective treatments for pediatric cancer that will cure the disease.
The center’s new building is home to several research laboratories and offices. The building contains a 100-seat research seminar room and a large conference room. Researchers can also utilize the building’s cleanroom for cell therapy research. The Center also provides clinical trial training for medical students.
Center for Cellular and Molecular Therapeutics
The Raymond G. Perelman Center for Cellular and Molecular Therapeutics at the Children’s Hospital of Philadelphia was recently recognized as a “Facility of the Year” by the International Society for Pharmaceutical Engineering. The Center houses state-of-the-art facilities for developing and manufacturing adenoassociated and lenti viral vectors.
The Center has committed more than $250 million in institutional and philanthropic support to advance this important area of research. Living therapeutics are the next generation of medicine and have been dubbed the “third pillar” of medicine. They are a class of drugs that are made from human, microbial, and engineered cells.
Research conducted at the Center for Cellular and Molecular Therapeutics aims to revolutionize the treatment of genetic and cellular disorders. Its multidisciplinary approach to leading edge research focuses on gene transfer, regulation, and discovery, as well as cell therapy and experimental models. Ultimately, these studies should lead to treatments for a wide range of diseases, including infectious diseases, heart disease, cancer, and other complex disorders.